Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H32N2O5 |
| Molecular Weight | 368.4678 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@H](N[C@H](C)C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(O)=O)C(=O)OCC
InChI
InChIKey=IPVQLZZIHOAWMC-OWYFMNJBSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14+,15+,16+/m1/s1
| Molecular Formula | C19H32N2O5 |
| Molecular Weight | 368.4678 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(2'R,3AR)-2',3A-di-epi-Perindopril is an epimer (S, RS, RS) of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. This form of the drug is much less active.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:03:04 GMT 2025
by
admin
on
Mon Mar 31 23:03:04 GMT 2025
|
| Record UNII |
F4ELM88F0Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
72941694
Created by
admin on Mon Mar 31 23:03:04 GMT 2025 , Edited by admin on Mon Mar 31 23:03:04 GMT 2025
|
PRIMARY | |||
|
F4ELM88F0Z
Created by
admin on Mon Mar 31 23:03:04 GMT 2025 , Edited by admin on Mon Mar 31 23:03:04 GMT 2025
|
PRIMARY | |||
|
145513-59-3
Created by
admin on Mon Mar 31 23:03:04 GMT 2025 , Edited by admin on Mon Mar 31 23:03:04 GMT 2025
|
PRIMARY |